CITIC Securities Co., Ltd.(600030)
Search documents
中广核电力(01816.HK)获中信证券资管增持2362万股
Ge Long Hui A P P· 2025-12-10 23:08
| 豪格序號 | 大股東/董事/最高行政人員名稱 作出披露的 買入 / 賣出或涉及的股 每股的平均價 | | | | 持有權益的股份數目 佔已發行的 有關事 | | | --- | --- | --- | --- | --- | --- | --- | | | 份數目 | 原因 | | | (請參閱上述*註解) 有投票權股 (日/月 | | | | | | | | 份百分比 | | | | | | | | 96 ) | | | CS20251210E00015 | 中信证券资产管理有限公司 | 1101(L) | 23,620,000(L) | HKD 3.0178 | 1.908.550.000(L) | 17.10(L)09/12/ | | 股份代號: | 01816 | | --- | --- | | 上市法國名稱: | 中國廣核電力股份有限公司 - H股 | | 日期 (日 / 月 / 年): | 11/11/2025 - 11/12/2025 | 格隆汇12月11日丨根据联交所最新权益披露资料显示,2025年12月9日,中广核电力(01816.HK)获中信证券资产管理有限公司在场内以每股均价3.01 ...
中信证券资管增持中广核电力2362万股 每股作价约3.02港元
Zhi Tong Cai Jing· 2025-12-10 11:30
香港联交所最新资料显示,12月9日,中信证券资产管理有限公司增持中广核电力(01816)2362万股,每 股作价3.0178港元,总金额约为7128.04万港元。增持后最新持股数目约为19.09亿股,最新持股比例为 17.10%。 ...
中信证券资管增持中广核电力(01816)2362万股 每股作价约3.02港元
智通财经网· 2025-12-10 11:21
智通财经APP获悉,香港联交所最新资料显示,12月9日,中信证券资产管理有限公司增持中广核电力 (01816)2362万股,每股作价3.0178港元,总金额约为7128.04万港元。增持后最新持股数目约为19.09亿 股,最新持股比例为17.10%。 ...
周大生:接受中信证券等投资者调研
Mei Ri Jing Ji Xin Wen· 2025-12-10 09:23
Group 1 - The core viewpoint of the news is that Zhou Dasheng (SZ 002867) is actively engaging with investors, indicating a focus on transparency and communication regarding its business operations [1] - Zhou Dasheng's revenue composition for the first half of 2025 is entirely from jewelry, with a 100.0% contribution from this segment [2] - As of the latest report, Zhou Dasheng's market capitalization stands at 13.1 billion yuan [3]
经纬恒润跌1.76% 2022年上市募36亿中信证券保荐
Zhong Guo Jing Ji Wang· 2025-12-10 09:07
Core Viewpoint - The stock price of Jingwei Hengrun (688326.SH) has declined, closing at 92.62 yuan, representing a drop of 1.76%, and is currently in a state of loss since its IPO [1] Group 1: Company Overview - Jingwei Hengrun was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on April 19, 2022, with an initial offering price of 121.00 yuan per share [1] - The company issued 30 million shares during its IPO, raising a total of 363 million yuan, with a net amount of 348.8 million yuan after deducting issuance costs [1] - The final net fundraising amount was 151.2 million yuan less than the original plan of 500 million yuan [1] Group 2: Fund Utilization - The funds raised are intended for several projects, including the establishment of an automotive electronics production base in Nantong, a research and development center in Tianjin, digital capability enhancement, and to supplement working capital [1] Group 3: Issuance Costs - The total issuance costs for the IPO amounted to 14.2 million yuan, with underwriting and sponsorship fees accounting for 10.4 million yuan [2]
君赛生物向港交所提交上市申请
Jin Rong Jie· 2025-12-10 09:00
本文源自:金融界AI电报 据港交所文件,上海君赛生物股份有限公司向港交所提交上市申请书,独家保荐人为中信证券。 ...
盛新锂能:4663.09万股非公开发行股份12月15日解禁
Xin Lang Cai Jing· 2025-12-10 08:47
Core Viewpoint - The announcement from Shengxin Lithium Energy indicates that 46.6309 million shares, representing 5.09% of the company's total share capital, will be released from restrictions, with BYD as the shareholder [1] Group 1: Share Issuance Details - The number of shares to be released from restrictions is 46.6309 million [1] - This release accounts for 5.09% of the total share capital of the company [1] - The total share capital has increased from 911,895,872 shares to 915,293,872 shares since the formation of the restricted shares [1] Group 2: Compliance and Approval - As of the announcement date, shareholders have strictly adhered to the share restriction commitments [1] - There are no instances of non-operational occupation of company funds or illegal guarantees [1] - The sponsor institution, CITIC Securities, has approved the release of the restricted shares for public trading [1]
华芢生物通过港交所聆讯,华泰国际、中信证券为联席保荐人
Jin Rong Jie· 2025-12-10 08:34
| 编纂I項下的[编纂]數目 : [编纂]股H股份(視乎[编纂]行使與否 | | --- | | 间足) | | [编纂 數目 [编纂]股H股股份(可予[编纂]) | | [编纂]數目 : [编纂]股H股股份(視乎[编纂]行使與否而定及可予 | | [编纂]) | | 最高[编纂] : 每股H股股份不超過[缓纂]港元,另加1.0%經紀開 | | 金、0.0027%證監會交易做費、0.00015%會財局 | | 交易微费及0.00565%香港聯交所交易費(須於[編 | | 暴 時以港元藏足,多織股款可于退還) | | 面值 : 每股H股股份人民幣1.00元 | | [编纂] : 【岩震】 | | 幕席保测人、[编纂] | | J. L. DARKERS SECURE FRANCE Callery . . Whichood Mic | 据港交所12月10日披露,华芢生物科技(青岛)股份有限公司-B(简称:华芢生物)通过港交所主板上市聆 讯,华泰国际、中信证券为联席保荐人。 招股书显示,该公司成立于2012年,是一家总部位于中国的生物制药公司,致力于开发各类疗法,重点 是针对有医疗需求及市场机会的适应症开发蛋白质药 ...
慧谷新材过会:今年IPO过关第87家 中信证券过10单
Zhong Guo Jing Ji Wang· 2025-12-10 02:42
Group 1 - The Shenzhen Stock Exchange's listing review committee approved Guangzhou Huigu New Materials Technology Co., Ltd. for its initial public offering (IPO), marking the 87th company approved this year [1] - Huigu New Materials focuses on polymer materials, specifically the research, production, and sales of functional resins and coating materials [2] - The company plans to issue up to 15,779,100 shares, aiming to raise 90 million yuan for various projects, including the expansion of an environmentally friendly coating and resin production facility [3] Group 2 - The major shareholders of Huigu New Materials include Shangnengde (30.69%), Yishang Investment (28.33%), Huiguanghong (16.53%), Tang Jing (11.80%), and Jinchenglaimao (7.08%), with no single shareholder having controlling power [2] - Tang Jing is identified as the actual controller of the company, holding a total of 59.02% of the voting rights through direct and indirect shareholdings [2][3] - The company has no controlling shareholder due to the distribution of shares among its major shareholders [2] Group 3 - The listing committee raised questions regarding the competitive landscape of Huigu New Materials' business segments, the technological development trends, and the sustainability of revenue growth [4]
中信证券:将中国平安A股列为“十大金股”第一位,偿二代三期有望成为股价催化剂
Ge Long Hui· 2025-12-10 02:36
该行指出,12月份市场面临美联储降息与否、中央经济工作会议部署、北美AI叙事争论等诸多变量, 但考虑到市场增量资金主要以保险资管、银行理财、量化私募等绝对收益导向资金为主,A股/港股可能 更多地像美股一样出现"急跌慢涨"。从配置角度看,资源/传统制造业定价权的重估、企业出海仍是核 心增配方向;此外,临近年末高切低也是投资者选择之一,不少交易不拥挤品种有望迎来配置机会。 股票频道更多独家策划、专家专栏,免费查阅>>责任编辑:栎树 12月10日,中信证券发布研报,更新2025年金股组合,将中国平安(601318.SH)列为高切低轮动精选个 股之一。该行指,中国平安在利率周期上判断比同业前瞻,长债持仓和高股息布局领先市场,银保扩展 和保单价值率提升领先市场,保险合同服务边际正在筑底向好,质变正在发生,阿尔法回报略慢但较为 确定;同时,公司及时大幅提升股票仓位,贝塔属性显著增强,牛市周期盛宴刚刚开始。该行期待进一 步推动逆周期监管,偿二代三期工程有望成为股价催化剂。 ...